MONDAY 30 June 2025 – Pre-Conference Sessions
Details to follow
Chair: Dr Arti Bakshi and Dr Catherine Stefanato
Programme:
11.00-12.15: Welcome and Cases 1-10
12.15-13.15: Lunch
13.15-15:45: Cases 11-30
15:45-16:15: Break
16:15-17:30: Cases 30-40
Speakers:
Dr Anoud Zidan
Dr Asok Biswas
Dr Cynthia Heffron
Dr Bipin Matthews
Dr Eleni Ieremia
Dr Kris Holt
Dr Nathan Asher
Dr Nitin Khirwadkar
Dr Somaia Elsheikh
Dr William Rickaby
| Time | Session | Speaker |
| 1300 | Introduction/housekeeping | Mitesh/Anna |
| 1305 | Biologics | Dr Makrygeogeou |
| 1335 | Photodermatology | Prof Ibbotson |
| 1405 | Rheum-Dermatology | Dr Meggitt |
| 1435 | Tele dermatology | Dr Tejal Patel |
| 1505 | BREAK | |
| 1520 | Nail disease | Dr Mowbray |
| 1550 | Tertiary clinic cases | Dr Steyn |
| 1620 | Paediatrics | Dr Goodwin |
| 1650 | Vasculitis | Dr Law |
12:55 – 13:00 Welcome
Dr Rosemary Akinbisehin
13:00 – 13:30 How to analyse and outcome teledermatology referrals
Dr Tejal Patel
13:30 – 14:00 Paediatric skin cancer – when to biopsy?
Dr Paula Beattie
14:00 – 14:30 Vulval disease – top tips
Dr Fiona Lewis
14:30 – 15:00 Considerations in the presentation and management of hair conditions with afro texture
Dr Sharon Belmo
15:00 – 15:30 Dermoscopic approach to flat red lesions
Dr Ausama Atwan
15:30 – 16:00 Paediatric skin cancer – when to biopsy?
Dr Paula Beattie
16:00 – 16:30 Plants and the skin
Dr Natalie Stone
16:30 – 17:10 Portfolio pathway Q&A
Dr Shalini Narayan & Dr Ava Lee
17:10 – 17:15 Close
How to Peer Review Workshop
Cost £50
This workshop is aimed at consultant dermatologists/trainees who have no prior experience of journal peer review.
BAD journals welcome consultant dermatologists, trainees or anyone who would like to review for us. We are offering a hands-on practical course to help you understand the concepts of peer review, why you should peer review and importantly work in small groups with some of our more experienced co-editors from CED and SHD using short papers from the journal. This is a beginner’s course for anyone daunted by the prospect of doing peer review. It is CPD-accredited by the RCP.
The objective of this course is to give:
– an insight into the peer review process within academic journals,
– gain an understanding of peer review models and systems
– practical experience of reviewing
PANEL:
Andrew Finlay
Alexa Shipman
Ser-Ling Chua
John McGrath
Ewan Langan
Adam Daunton
Details to follow
TUESDAY 1 JULY 2025
| PROGRAMME | ||
| 08:31 – 08:38 | CPC01 | Eosinophilic cellulitis in the setting of cocaine use Li Jie Helena Yoo, Midhu Sunnyraj, Stephen Crowther, Johnny McHugh, Patrick Mitchell, Caitriona McEvoy, Allyson Egan and Caitriona Hackett |
| 08:38 – 08:45 | CPC02 | Follicular eruption unravelling a systemic disease: a clinicopathological correlation Anubha Dev, Debajyoti Chatterjee and Dipankar De |
| 08:45 – 08:52 | CPC03 | Unusual cases of scalp ulceration: two distinct diagnoses
Sonali Gupta and Shreya K |
| 08:52 – 08:59 | CPC04 | Avelumab-induced sarcoidosis during therapy for metastatic Merkel cell carcinoma Tiffany Tuhirman and James Coe |
| 08:59 – 09:06 | CPC05 | 34BE12 is the most reliable marker for keratin-derived primary cutaneous amyloidosis Ghadah Al-Sharbatee, Maged Daruish, Corrado D’Arrigo and Saleem Taibjee |
| 09:06 – 09:13 | CPC06 | Darier–Roussy disease (subcutaneous sarcoidosis): a rare presentation of cutaneous nodules in pulmonary sarcoidosis Stephanie Adeyemi, Leah Mapara and Faris Kubba |
| 09:13 – 09:20 | CPC07 | Lines of evidence: unravelling a case of blaschkoid Darier disease Emma Carroll, Maeve Herlihy, Cian Ward, Kieran Sheahan and Aisling Ryan |
| 09:20 – 09:27 | CPC08 | Acrodermatitis enteropathica in adulthood secondary to acquired zinc deficiency: a diagnostic challenge Fei Ya Lai and Kevin Molloy |
| 09:27 – 09:34 | CPC09 | Recurrent extramammary Paget disease and colorectal adenocarcinoma Savitri Chandrasekaran, Laura Adams, Matthew Sommerlad and Helen Lotery |
| 09:34 – 09:41 | CPC10 | A waxy wonder: unveiling a rare dermatological mystery Ji Fung Yong, Li Jie Helena Yoo, Stephen Crowther, Anne-Marie Tobin and Maureen Connolly |
| 09:41 – 09:48 | CPC11 | A case of vulval melanosis and depigmentation Natalie King Stokes, Shireen Velangi, Owen Cain and Emily Akufo-Tetteh |
| 09:48 – 09:55 | CPC12 | An unusual case of paraneoplastic sarcoid presenting as dactylitis Nora Makary, Louise Cunningham, Kavitha Sundararaj, Marie-Louise Daly and Monika Saha |
| 09:55 – 10:02 | CPC13 | BRAF mutations in melanoma: testing patterns, demographic associations and survival implications Zhenghao Wang,Polly Jeffrey, Dimitrios Karponis, Nick J. Levell, Zoe C. Venables, Sally Vernon and Khaylen Mistry |
| 10:02 – 10:09 | CPC14 | Blaschko-linear trichoepitheliomas: unveiling type 1 segmental mosaicism Sonali Gupta, Vaishnavi Verma and Sathvi KM |
| 10:09 – 10:16 | CPC15 | Vulval squamous cell carcinoma is an under-reported cancer associated with poor outcomes: a national cohort study of the incidence and survival in England Charlotte Sheern, Nick J. Levell, Birgitta van Bodegraven, Catherine Harwood, Andy Nordin, Jane Sterling and Zoe C. Venables |
| 11:00 – 11:12 |
|
The UK–Irish Atopic Eczema Systemic Therapy Register (A-STAR): a pilot descriptive analysis of healthcare resource use, costs and health-related quality of life in patients on systemic treatments for atopic eczema
Carlos Chivardi, Elizaveta Gribaleva, Bolaji Coker, Man Fung Tsoi, Rebecca Carroll, David Prieto-Merino, Manisha Baden, Paula E. Beattie, Sara Brown, Tim Burton, Ross Hearn, John R. Ingram, Alan D. Irvine, Graham A. Johnston, Irene Man, Graham Ogg, Mandy Wan, Richard B. Warren, Richard T. Woolf, Nick J. Reynolds, Michael R. Ardern-Jones, Carsten Flohr and Andrea Manca |
||
| 11:12 – 11:24 |
|
Skin cancer service disparities across England: what data can tell us about skin cancer diagnosis, referral pathways and treatment received in different NHS trusts
Birgitta van Bodegraven, Sally Vernon, Shehnaz Ahmed, Tania Von Hospenthal, Michael R. Ardern-Jones, Tanya Bleiker, Chris Bower, Stephen Keohane, Nick J. Levell and Zoe C. Venables |
||
| 11:24 – 11:36 |
|
Implications of the implementation of the new UK regulatory framework for the prescribing of isotretinoin: an assessment of the impact on outpatient capacity
Julia Schofield and Christopher Bunker |
||
| 11:36 – 12:48 |
|
Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
Hans Johnson, David Huang, Ashley K. Clift, Ângela Bersch-Ferreira3 and Gabriel A. Guimarães |
||
| 11.50 – 12:15 |
|
Dr Tanya Bleiker (Derby) Outpatient Transformation Project |
| PROGRAMME | ||
| 15:15 – 15:45 | KL01 | Keynote Lecture Advanced Wearable Devices for Dermatology Prof John Rogers ( Evanston, IL, United States) |
| 15:45 – 16:15 | KL02 | Keynote Lecture Molecular profiling of inflammatory skin disease Prof Michel Gilliet ( Lausanne, Switzerland) |
| 16:15 – 16:45 | KL03 | Keynote Lecture Development of AI for retinal images and lessons for skin AI Prof Manuel Trucco (Dundee) |
| 16:45 – 17:15 | KL04 | Keynote Lecture Using Technology in the Skin Cancer Clinic Assoc. Prof Alex Chamberlain (Melbourne, Australia) |
| 17:15 – 18:30 | BAD AGM & Awards Presentation | |
| PROGRAMME | ||
| 08:30 – 09:00 | AGM | |
| 09:00 – 09:10 | CD01 | Contact allergy to alkyl glucosides: a multicentre audit in the UK and Ireland
Livia Francine Soriano, Natalie M. Stone, David I. Orton, Catriona Wootton, Donna A. Thompson, Philippa Cousen, Tracey Finch, Mahbub M.U. Chowdhury, Graham A. Johnston, Elizabeth Kate Mulcahy, Tang Ngee Shim, Simon A. Dawe, Sarah Wakelin, Sharizan Abdul Ghaffar, Avad A. Mughal, Krisztina Scharrer, Sara O’Kelly, Faheem Latheef and Deidre A. Buckley |
| 09:10 – 09:20 | CD02 | Colophonium derivatives as key allergens in diabetes technology-associated allergic contact dermatitis: a hidden concern in the British Society for Cutaneous Allergy standard series
Fiona Sexton, Julia O’Mahony, Sumera Sumera, Romina Golchin, Cecilia Svedman, Niamh O’Boyle, Colin P. Hawkes and John Bourke |
| 09:20 – 09:30 | CD03 | Heavy is the crown: hidden allergy in dental restorations
Caitlin McNeill and Donna Thompson |
| 09:30 – 09:40 | CD04 | Hydroquinone allergic contact dermatitis: widening the potential dangers of black henna tattoos
Kalina Bridgewater and Natalie Stone |
| 09:40 – 09:50 | CD05 | The hazards of patch testing in a patient with Hailey–Hailey disease
Beenish Afzal, Catherine Holden and David Gawkrodger |
| 09:50 – 09:55 | Question and Answer | |
| 09:55 – 10:15 | Invited Talk
Chlorhexidine Allergy Dr Louise Savic (Leeds) |
|
| 10:15 – 11:00 | Break | Exhibition Hall |
| 11:00 – 11:10 | CD06 | Wiped out: the current landscape of allergens in baby wipes in the UK
Yuma Kitahara and Livia Soriano |
| 11:10 – 11:20 | CD07 | Cananga oil and ylang ylang oil: different haptens but with the same INCI name. The importance of patch testing to both
Tharindri Wijekoon, Catherine Holden and David Gawkrodger |
| 11:20 – 11:30 | CD08 | Occupational asthma and allergic contact dermatitis in a toolmaker
Katherine Lewis, Yuma Kitahara, Joanna Szram and Livia Soriano |
| 11:30 – 11:40 | CD09 | Complexities of contact dermatitis: lessons from a case of concomitant budesonide and propylene glycol sensitivity
Harsharan Kaur Bansal and Donna Thompson |
| 11:40 – 12:10 | Prosser-White Oration
Clinical perspective on cutaneous drug allergy Professor Margarida Gonçalo (Coimbra, Portugal) |
|
| POSTERS | ||
| CD10 | Challenges with chambers: a case of contact allergy to patch test units
Harsharan Kaur Bansal and Donna Thompson |
|
| CD11 | Cutaneous allergy documentation in primary care
Yan Lynn Ng, Sareena Gajebasia and Sharizan Abdul Ghaffar |
|
| CD12 | Severe allergic contact dermatitis to jagua henna temporary tattoo
Sarah Elhabrouk, Caitlin McNeill and Donna Thompson |
|
| CD13 | Occupational hand dermatitis: a rare case of isolated methenamine allergy in nitrile gloves
Prabhav Singhal and Donna Thompson |
|
| CD14 | ‘Alien mask’ allergic contact dermatitis: a case of multisensitization highlighting the importance of a comprehensive hobby history
Katie Creamer and Natalie Stone |
|
| CD15 | Diving into wetsuit contact allergy secondary to black rubber
Mehak Chadha, Faheem Latheef and Mark Wilkinson |
|
| CD16 | Tackling shinpad contact dermatitis to acetophenone azine with generalization: autosensitization or presence in clothing?
Mehak Chadha and Faheem Latheef |
|
| CD17 | A survey of cosmetic product use and contact skin reactions in children: a decade later
Huei Xin Teo, Claudia Cameron and Sharizan Ghaffar |
|
| CD18 | Prevalence of allergic contact dermatitis in the paediatric population: a 6-year retrospective review of two patch testing centres
Katie Creamer, Emelie Hutton, Natalie Stone, Mahbub M.U. Chowdhury and Ru Katugampola |
|
| CD19 | Contact allergy to colophonium and Abitol in a continuous glucose monitor securing tape
Arnav Katira and Catherine Holden |
|
| CD20 | Allergic contact dermatitis due to a rosary necklace
Danning Li and Tang Ngee Shim |
|
| CD21 | Things can only get redder! Two cases of allergic contact dermatitis to topical brimonidine tartrate gel
Katie Creamer and Natalie Stone |
|
| CD22 | Labelling of medical devices used in dermatology
Farah Ariana Faizi and Sharizan Abdul Ghaffar |
|
| CD23 | A scoping review on the use of dupilumab in allergic contact dermatitis
Annabelle Xiao Hui Lim, William Tuckwell, Jui Vyas and Mahbub M.U. Chowdhury |
|
| CD24 | Irritant contact dermatitis from Dieffenbachia schott: a case report of a florid reaction to a common household plant
Evangelia Vetsiou and Angela Tewari |
|
| CD25 | Eczema flares mediated by oral exposure to nickel
Louay Abdulkarim, Isabella Wolfe, Emily Ko, Beatriz Suarez Martinez-Falero and Michael R. Ardern-Jones |
|
| Service planning, patient centred care & sustainability | ||
| 08:50 – 08:58 | DS01 | “An app a day keeps the consultations at bay!” Introducing a novel patient communication app to optimise the fast-track skin cancer ‘direct to surgery’ pathway |
| 09:00 – 09:08 | DS02 | Advancing the Understanding and Treatment of Cutaneous Squamous Cell Carcinoma: The Role of the UK Keratinocyte Cancer Collaborative |
| 09:10 – 09:18 | DS03 | Ex vivo confocal laser scanning microscopy of 83 facial basal cell carcinomas: A single-centre prospective one year study of real-world Mohs experience |
| 09:20 – 09:28 | DS04 | Dilemmas during Mohs surgery; adjacent Trichoepithelioma and Basal Cell Carcinoma: Clinical and Histological Challenges. |
| 09:30– 10:15 | DSGL | Guest Lecture My approach to managing high-risk SCC Dr Ashley Wysong (Omaha, United States) |
| 10:15 – 11:00 | Break | Exhibition Hall |
| 11:00 – 11:08 | DS05 | The UK’s First Outcome Analysis of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma from a Major Tertiary Center |
| 11:10 – 11:18 | DS06 | A national UK clinician and patient survey on surgical glove practices in dermatological surgery |
| 11:20 – 11:28 | DS07 | Surgical treatment for melanoma-in-situ and lentigo maligna: the impact of changing policy on wider excisions after adequate histological clearance |
| Surgical techniques – Rapid Fire session | ||
| 11:30 – 11:35 | DS08 | Expanding the reconstructive armamentarium: A case series utilising the pre-tragal perforator propeller flap |
| 11:35 – 11:40 | DS09 | An exploratory biomechanical experiment comparing ultimate tensile strength of ten suturing techniques including a novel suture utilised in high-tension closure |
| 11:40 – 11:45 | DS10 | Use of “deckling” incisions in facial dermatologic surgery; a case series |
| 11.45 – 11.50 | DS11 | Excising lesions on the scalp and temple – a technique to minimise intra operative haemorrhage |
| 11.50 – 11.55 | DS12 | Mini Monoka Stent use to preserve the canaliculi of the lacrimal drainage system, during periocular Mohs surgery. |
| 11.55 – 12.00 | DS13 | Biodegradable Temporising Matrix (BTM): A First For Dermatologic Surgery and a Valuable Reconstructive Adjunct |
| 12.00 – 12.10 | Discussion Time | |
| 12:10 – 13:15 | Lunch | Exhibition Hall |
| 13:15 – 13:45 | Focus Session Top tips for nail surgery and nail lesion diagnosis Dr David De Berker (Bristol, UK) |
|
| 13:45 – 14:30 | EQA feedback discussion | |
| 16:15 – 17:00 | AGM | |
| POSTERS | ||
| DS12 | Shocking Practices: A Survey of Cardiac Device Management in Dermatologic Surgery | |
| DS13 | Comparing the costs of monitoring vs. excision of an indeterminate naevus | |
| DS14 | Prosthetic Joint Infections in Dermatological Surgery – A Survey of British Society for Dermatological Surgery (BSDS) Members | |
| DS15 | A retrospective review of Mohs micrographic surgery (MMS) for periocular malignancy at a teaching hospital: A 10 year review | |
| DS16 | Living with Dermatofibrosarcoma Protuberans – Patients’ Perspective on Health-Related Quality-of-life Measures | |
| DS17 | Nail surgical techniques: a review of current evidence and how to optimise surgical outcomes | |
| DS18 | Impact of Delays in Surgical Management of Skin Cancer | |
| DS19 | Mohs Surgeons had higher rates of detecting missed margins than Consultant Histopathologists when auditing Mohs slides | |
| DS20 | “We need to talk”: The effect of departmental discussion of BSDS sustainability guidance on use of absorbable suture material and its environmental impact | |
| DS21 | Challenging Dogma in Dermatological Surgery | |
| DS22 | Secondary intention healing should be offered for shallow lower lip defects involving the vermilion border following Mohs micrographic surgery | |
| DS23 | A Comparison of Surgical Intervention with Adjunct Laser Hair Removal against Primary Laser Hair Removal in Pilonidal Sinus disease: a post-hoc analysis of a retrospective cohort study | |
| DS24 | Recurrence and Histological Adequacy of Cutaneous Squamous Cell Carcinoma on the Head and Neck Treated with Triple Curettage and Cautery: A Five-Year Retrospective Review | |
| DS25 | Checking blood pressure of patients having Mohs surgery; a survey of practice of United Kingdom and Australasian-based Mohs surgeons | |
| 08:30 – 08:35 | Welcome & Introduction | |
| 08:35 – 08:40 | BI01 | Persistent non-pruritic scabies in a patient on Nemolizumab for the treatment of Prurigo Nodularis. Bindi Gaglani, Elaine Agius, Richard Woolf, Catherine Smith, Andrew Pink |
| 08:40 – 08:45 | BI02 | Abrocitinib-Induced Kaposi Sarcoma in a Patient with Severe Atopic Dermatitis. Puo Nen Lim, Miriam O’Connor, Gabrielle Becher |
| 08:45– 08:50 | BI03 | Erythrodermic Psoriasis Following Second Cycle of Cemiplimab: A Case Report. David Rutkowski, Ashish Sharma, Shanti Ayob, Thomas Moore, Ananth Sivanandan |
| 08:50 – 08:55 | BI04 | Bullous pemphigoid induced by Cemiplimab to treat metastatic squamous cell carcinoma in a renal transplant patient. Melissa Freneat, Ling Li, Rebecca Shakir, Husham Abuleis, Antonia Lloyd-Lavery |
| 08:55 – 09:00 | BI05 | Cemiplimab Toes: A new entity in the expanding spectrum of immune checkpoint inhibitor skin toxicities. Majeeda Patel, Michael-John Devlin, Sukaina Rashid, Shantini Crusz, Catherine Harwood |
| 09:00– 09:07 | BI06 | Global perspective on skin cancer in organ transplant recipients with skin of colour: a systematic review. Jeva Cernova, Ioannis Theocharopoulos, Xiangli Tan, Muhammad Hyder Junejo, Barbara Marzario, Catherine Harwood |
| 09:07 – 09:14 | BI07 | Management of severe psoriasis in patients with concomitant malignancy: a retrospective observational study. Puo Nen Lim, Gabrielle Becher, Areti Makrygeorgou |
| 09:14 – 09.21 | BI08 | A Prospective Observational Study exploring the Incidence and Impact of Cutaneous Toxicities in Patients undergoing Oncological Treatment. Orlaith Kelly, Danielle Cotter, Ciara Drumm, Aoife Lally, Blaithin Moriarty |
| 09:21 – 09:28 | BI09 | The OCTOPUS study (Optical Coherence Tomography in OutPatient dermatology UnitS): can non-invasive imaging improve diagnosis of keratinocyte (pre)cancers in immunosuppressed and immunocompetent patients? Emilia Peleva, Majeeda Patel, Xiang Li Tan, Suchitra Chinthapalli, Rebeca Goiriz, Zeeshaan Hasan, Sarah Hogan, Nav Paul, Shefali Rajpopat, Anshoo Sahota, Jason Thomson, Stela Ziaj, Catherine Harwood, Kapil Bhargava |
| 09:28 – 09:35 | BI10 | Translating Clinical Trials into Practice: Real-life experience using mogamulizumab in the treatment of Mycosis Fungoides and Sézary Syndrome in a single centre of 29 patients. James Ellis, Mary Wain, Fiona Child, Sean Whittaker, Van Sim, Stephen Morris, Bjorn Thomas |
| 09:35 – 09:42 | BI11 | Squamoid Eccrine Ductal Carcinoma: a case series of an aggressive skin cancer occurring almost exclusively in immunocompromised patients. Xiang Li Tan, Pooja Patel, Jeva Cernova, Sarah Hogan, Efthymios Hadjimichael, Dorota Mankiewicz, Sharanpal Jeetle, Michael Sheaff, Giorgia Trevisan, Nilukshi Wijesuriya, Graeme Moir, Matt Stodell, Kapil Bhargava, Suchitra Chinthapalli, Catherine Harwood |
| 09:42 – 09:49 | BI12 | Systematic review of checkpoint inhibitor-induced epidermal necrolysis: a clinical entity distinct from ‘classic’ Stevens-Johnson syndrome / toxic epidermal necrolysis. Rebecca Creamer, Mark Harries, Daniel Creamer, Freya Hamar-Davies |
| 09:50-10:15 | BI13 | Update on the development of a consensus statement on behalf of BSSCII: delivering stratified skin cancer surveillance in solid organ transplant recipients. Farrah Bakr, Mhairi Duncan, Mary Wain, Rubeta Matin, Conal Perrett, Ferina Ismail, Catherine Harwood, Charlotte Proby, Tanya Basu |
| 10:15 – 10:45 | Break | Exhibition Hall |
| 10:45 –10:52 | BI14 | Case Series – Exploring the link between psoriasis and CDK4/6 inhibitors in breast cancer treatment. Gemma McDonnell, Sophie Diong, Maeve Lynch |
| 10:52 – 10:59 | BI15 | Immunosuppression increases the risk for HPV8 associated keratinocyte carcinoma. William Tuckwell, Huw Morgan, Nitya Malladi, Girish Patel |
| 10:59 – 11:06 | BI16 | The COAST (Contemporary Outcomes After cutaneous SCC in Transplant recipients) study: final results and implications for management following the first cutaneous squamous cell carcinoma in kidney transplant recipients. Emilia Peleva, Tom Crisp, Jeva Cernova, Khizr Nawab, Maria Angela Gauci, Jonathan Gamble, Buddhika Wijayawickrama, Rabiah Ahmed, Jim Moriarty, Rubeta Matin, Rachel Abbott, Amrit Darvay, Farida Shah, Charles Archer, Nina Muirhead, Alex Owen, Nitin Bhandary, Harry Wakefield, Adarsh Babu, Elizabeth Wallin, Adnan Sharif, Sian Griffin, Raj Thuraisingham, Pippa Bailey, Catherine A Harwood, Matthew Bottomley |
| 11:06-11:10 | Discussion time / introduction of invited speaker | |
| 11:10– 11:55 | Guest Speaker: Dr Ashley Wysong (Omaha, United States) ‘Transformative Updates in Skin Cancer Care for Immunosuppressed Patients’ |
|
| 11:55 – 12:25 | AGM
All BSSCII members most welcome and invited to contribute |
Joint BAD/BSD Neil Smith Lecture
Mycosis fungoides immunophenotypic variants
Prof Emilio Berti (Milan, Italy)
Guest speaker
Aggressive primary cutaneous T-cell lymphomas: alpha/beta and gamma-delta
Prof Emilio Berti (Milan, Italy)
| Guest Lecture Learning about learning: can we improve medical student placements? Dr Ana Sergio Da Silva (Swansea) |
Guest Speaker:
- Cultural Practices and Ethical Challenges in Dermatology: A Global Perspective
Dr Antoine Petit (Paris, France)
| 13:15 – 13:20 | Introduction & Welcome | |
| 13:20 – 13:40 | Dr Louise Savic (Leeds) Penicillin Delabelling |
|
| 13:40 – 14:00 | Dr Chris Rutkowski (London) Excipient Allergy |
|
| 14:00 – 14:20 | Dr Ying Teo (Southampton) The value of patch testing to find the cause of drug allergy reaction |
|
| 14.20 – 14:30 | Panel Discussion |
Dermoscopy Session : Special Sites
Chair: Dr Ben Esdaile (London) and Dr Jonathan Bowling (Oxford)
15:15 – 15:40 ‘Onychoscopy: tips to nail the diagnosis”
A/Prof Alex Chamberlain (Melbourne, Australia)
Interactive Case Based Learning:
15:45 – 16:05 Face – Cases 1-10
Dr Jonathan Bowling, Oxford
16:05 – 16: 25 Lips and scalp – Cases 11-20
Dr Ausama Atman, Newport
16:25 – 16: 45 Acral Sites – Cases 21-30
Dr Ben Esdaile, London
The BAD AGM will take place in-person in the Lomond Lecture Theatre
WEDNESDAY 2 JULY 2025
| PROGRAMME | ||
| 08:45 – 09:00 | O05 | A retrospective review of cases of psoriasis requiring discontinuation of biologic therapy from 2007 to 2024 in a multisite NHS trust Younghoon Kim, Daniel Yi Liang Tan, Anthony Bewley, Padma Mohandas and Sarah Mehrtens |
| 09:00 – 09:15 | O06 | Association between novel systemic immunomodulatory medications and achievement of super response in patients with moderate-to-severe atopic eczema: results from the UK–Irish Atopic Eczema Systemic Therapy Register (A-STAR) Man Fung Tsoi, Elizaveta Gribaleva, David Prieto-Merino, Rebecca Carroll, Bolaji Coker, Manisha Baden, Paula E. Beattie, Sara J Brown, Tim Burton, Ross Hearn, John R. Ingram, Alan D. Irvine, Graham A Johnston, Irene Man, Graham Ogg, Mandy Wan, Richard B. Warren, Richard T. Woolf, Nick J. Reynolds, Michael R. Ardern-Jones and Carsten Flohr |
| 09:15 – 09:35 | Inv02 | Invited Talk Considering comorbidities in Treatment choices for Moderate to Severe Eczema Dr Paula Beattie (Glasgow) |
| 09:35 – 09:55 | Inv03 | Invited Talk TBC |
| 09:50 – 10:10 | Inv04 | Invited Talk An update in the treatment of Hidradanitis Dr Hannah Wainman (Bristol) |
| 10:10 – 11:00 | Break | Exhibition Hall |
| 11:00 – 11:15 | O07 | Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) Heber Rew Bright Bright, Mark Lunt, Richard B. Warren and Zenas Yiu |
| 11:15 – 11:30 | LB01 | Late Breaking Abstract |
| 11:30 – 11:50 | Inv05 | Invited Talk An update in the treatment of Connective Tissue Disease Dr Aveen Connelly (London) |
| 11:50 – 12:10 | Inv06 | Invited Talk Top tips from the vulval clinic Dr Helen Lotery (Southampton) |
| 12:10 – 12:30 | Inv07 | Invited Talk Modern management of Pyoderma Gangrenosum Dr Phil Hampton (Newcastle) |
| PROGRAMME | ||
| 14:00 – 14:15 | O08 | Lentigo maligna survival: balancing treatment decisions in those with limited life expectancy Kate Quirke, Birgitta van Bodegraven, James Powell and Zoe C. Venables |
| 14:15 – 14:35 | Inv08 | Invited Talk Advances in non melanoma skin cancers: what all dermatologists need to know Dr Ashley Wysong (Omaha, United States) |
| 14:35 – 14:50 | O09 | From skin to gut: the journey of metastatic melanoma in the gastrointestinal tract Ai Shuen Hew, Angana Mitra and Maria Marples |
| 14:50 – 15:10 | Inv09 | Invited Talk Cosmetic complications that all dermatologists need to know about Dr Hayley Leeman (London) |
| PROGRAMME | ||
| 16:00 – 16:30 | KL05 | Keynote Lecture – Patient Perspective Introduced by John HumphrysPersonal Journey Sir Chris Bryant MP |
| 16:30 – 16:50 | Inv10 | Invited Talk AI and technology in healthcare: myth or reality Dr Margaret McCartney (Glasgow) |
| 16:50 – 17:35 | Question Time | Should the NHS introduce population screening for skin cancer? What benefits will AI bring to management of dermatology patients in the next 5 years?Chair: Prof Mike Ardern-Jones· Dr Zoe Venables · Dr Margaret McCartney · Prof Richard Weller · Dr Jonathan Bowling · Dr Steve Keohane · Dr Rubeta Matin |
| 17:35 – 17.40 | Chair Summary | |
Details to follow
| 09:00 – 09:05 | Introduction | |
| 09:05 – 09:15 | SG01 | Naltrexone: not a one trick pony for opioid overdose. The use of Naltrexone to successfully treat severe Hailey-Hailey Disease. |
| 09:15 – 09:25 | SG02 | Transdermal testosterone improves lower extremity ulceration in a young male with newly diagnosed Klinefelter’s syndrome (47 XXY) |
| 09:25 – 09:35 | SG03 | A rare diagnosis of tyrosinaemia type II in a patient with palmoplantar keratoderma |
| 09:35 – 10:05 | Invited Talk
The challenges and opportunities in newborn genome screening for genetic skin conditions in the Generation Study Dr David Bick (London) |
|
| 10:05 – 10:40 | Break | Exhibition Hall |
| 10:40 – 10:50 | SG04 | Early onset superficial spreading Melanoma and Macrocephaly: Think Cowden’s Syndrome |
| 10.50 – 11:00 | SG05 | Successful Use of Oral Methotrexate in Ferguson-Smith Syndrome |
| 11:00 – 11:10 | SG06 | Blaschkolinear hypopigmentation caused by GNA11 and PIK3CA mosaicism |
| 11:10 – 11:20 | SG07 | Real world experience with the use of IV gentamicin to induce nonsense mutation readthrough in an adult patient with recessive dystrophic epidermolysis bullosa |
| 11:20 – 11.30 | SG08 | Cutaneous features in classical Ehlers Danlos Syndrome: an update |
| 11.30 – 11:40 | SG09 | An epidemiological study of ichthyoses in England from 1998-2024 |
| 11:40 – 11:50 | SG10 | The epidemiology of Epidermolysis Bullosa in England, 1997-2024; a retrospective national cohort study. |
| 11:50 – 12:20 | Invited Talk
Identification and management of individuals with inherited cancer predisposition: improving diagnosis and surveillance through national initiatives Prof Helen Hanson (Exeter) |
|
| 12.20 – 12:30 | Concluding remarks |
| POSTERS | ||
| SG11 | Review of a multidisciplinary pathway for detection of Lynch syndrome following pathologic diagnosis of sebaceous neoplasms | |
| SG12 | A rare case of perianal granular cell tumour in a localised recessive dystrophic EB patient | |
| SG13 | 2023 Epidermolysis Bullosa Patient Insight Study: Understanding Carer Quality of Life | |
| SG14 | Homozygous pathogenic variant in transgradient PPK, causative, contributory or irrelevant? | |
| SG15 | Unraveling the Risk Factors for Hidradenitis Suppurativa: A Genetic Approach | |
| SG16 | Basal Cell Naevus Syndrome diagnosed in infancy | |
| PROGRAMME | |||
| 11:00 – 11:05 | Welcome – overview | ||
| 11:05 – 11:20 | BT01 | The effectiveness of telemedicine in dermatology services: a systematic review
Mueed Ijaz
|
|
| 11:20 – 11:35 | BT02
(P161) |
How safe are community lesion imaging clinics for teletriage of suspected skin cancer? A retrospective study
Hannah Morgan, Huw Greenish, Hafsa Faarax Shirwac, Emma Porter, Chloe White, Victoria Owen, Eveline Tucker, Colin Fleming and Alexander D.G. Anderson
|
|
| 11:35 – 11:50 | BT03 | Teledermoscopy vs. real-time dermoscopy for melanoma diagnosis: a 10-year review
Sanay Goyal, Sam Johnson, Ausama Atwan, Caroline Mills and Richard Goodwin
|
|
| 11:50 – 12:05 | BT04 | A dermatology image quality assessment tool for skin cancer teledermatology
Gillian Chin, Thanya Chartsakulkanajarn, Trisha Chin, Andrew Coon, Alyson Bryden and Colin Fleming
|
|
| 12:05 – 12:20 | BT05 | Developing a novel patient communication app to optimize the teledermatology fast-track skin cancer ‘direct-to-surgery’ pathway
Cleone Riad, Rachel Urwin, Jenny Fallon, Claire Machin and Walayat Hussain
|
|
| 12:20 – 12:35 | BT06
(P163) |
Implementation of a novel direct-to-patient inflammatory teledermatology service
Huw Greenish, Martha Chilton-Arias, Hannah Morgan, Emma Porter, Chloe White, Hafsa Faarax Shirwac and Alexander D.G. Anderson
|
|
| 12:35 – 12:50 | BT07 | BT07
A novel ‘super clinic’ model for registrar training in Advice and Guidance Oluwamayowa Aboluwarin, Aswatha Rabindranathnambi, Perin Celebi, Rabi Nambi and Tanya Bleiker |
|
| POSTERS | ||
| BT08 | Evaluating patient satisfaction: an insightful audit of our teledermatology service in tertiary care
Elena Ailenei, Prarthana Desai, Sana Sankey and Manju Paul
|
|
| BT09 | A picture saves a thousand seconds
Antonia D’Cruz, Imran Hafeez and Rakesh Patalay |
|
| BT10 | Introduction of a medical photography clinic as part of a community diagnostic centre pathway
Aswatha Rabindranathnambi, Oluwamayowa Aboluwarin, Rabi Nambi and Tanya Bleiker
|
|
| BT11 | Impact of teledermatology in a resource-limited setting: how the community responds to psychodermatology
Mandeep Joshi and Shambhu Joshi
|
|
| BT12 | Practical cybersecurity considerations for dermatology professionals
Inga Lawson and Faisal Dubash
|
|
| BT13 | A remote nurse prescriber service: enhancing capacity for new patients and streamlining services to ensure high-quality patient care and satisfaction
Andrew Morris and Sarah Copperwheat
|
|
| BT14 | An analysis of a phototriage service for an island community
Sarah Johnston and Alison Honan
|
|
| BT15 | Looking to the future: evaluation of outcomes of a teledermatology service pathway with an educational focus
Albana Krasniqi, Emine Senkal, Anna Nielsen-Scott and Cathryn Sprenger
|
|
| Invited Talk Swelling of the leg in the elderly. How much venous failure, how much lymphatic failure – Should we blame the epidermis and treat all three? Prof Terence Ryan (Oxford) |
| 14:00 – 14:10 | AIGL1 | Invited Talk Hanover Update Dr Rubeta Matin (Oxford) |
| 14:10 – 14:20 | AI01 | Advancing Skin Cancer Detection with Artificial Intelligence: Insights from a UKRI-Sponsored Competition Using Real-World Clinical Data |
| 14:20 – 14:40 | AIGL2 | Invited Talk Automated Detection of In-Hospital Drug Hypersensitivity Reactions Using a Privacy-Preserving Large Language Model Dr Frederic Dezoteux (Southampton) |
| 14:40 – 14:50 | AI02 | Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying BADBIR data |
| 14:50 – 15:10 | AIGL3 | Invited Talk How clinicians can develop AI for the clinic Dr Nick Fuggle (Southampton) |
| 15:10 – 15:20 | AI03 | Steps towards safely deploying the world’s first autonomous artificial intelligence as a medical device for skin cancer into an NHS teledermatology pathway |
| 15:20 – 15:30 | Panel Discussion |
| POSTERS | ||
| AI04 | 744 A Novel Machine Learning Software Application for Prognosticating Cutaneous Malignant Melanoma Based on Data from 78,351 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database | |
| AI05 | Practical Cybersecurity Considerations for Dermatology Professionals | |
| AI06 | ALUDWIG: An automated AI-based assessment of female androgenic alopecia | |
| AI07 | Evaluating the Quality of AI-Generated Research: A Comparison of Elicit and Systematic Reviews in Dermatology | |
| AI08 | Early detection of melanoma: Evaluating the combined use of total body photography and sequential digital dermoscopic imaging in a national health service setting. | |
| AI09 | Skin in the Game; Are A.I. Skin Checker Apps Held to a High Enough Standard? | |
| AI10 | Mobile Health Applications and Telemonitoring in Atopic Dermatitis: A Systematic Literature Review of Self-Management and Clinical Outcomes | |
| AI11 | Harnessing AI-based image analysis and self-reported data for the assessment of psoriasis severity | |
| AI12 | Prospective, multicentre, real-world sensitivities of an Artificial Intelligence as a Medical Device assessment and teledermatologist assessment in appropriately managing melanoma, squamous cell carcinoma and rare skin cancers referred on the urgent suspected cancer pathway | |
| AI13 | Development and Performance Evaluation of a Deep Learning Model for the Histopathological Diagnosis of Actinic Keratosis: A Diagnostic Case-Control-Accuracy Study | |
| AI14 | AI-Driven Digital Applications/Tools for Atopic Dermatitis – Understanding the Current Landscape | |
| AI15 | The use of Artificial Intelligence as a Medical Device and teledermatology in the assessment of Merkel cell carcinoma – an NHS case series | |
| AI16 | Performance of a Deep Neural Network in Diagnosing Lesions Referred on the Suspected Skin Cancer Pathway. A Prospective Observational Study. | |
| 14:00 – 14:10 | Welcome – Dr Alia Ahmed | |
| 14:10-15:05 | PSGL1 | Invited Talk
Dermatitis Artefacta- history and psychopathology. Prof Femi Oyebode (Birmingham)
|
| 15.05 – 15.17 | PS01 | Dermatitis artefacta in paediatric population: clinical insights from a retrospective review |
| 15:17 – 15.50 | Break | Exhibition Hall |
| 15:50 – 16:02 | PS02 | Patient satisfaction in virtual support group meetings for vitiligo: a service evaluation |
| 16:02 – 16:14 | PS03 | Tanning Dependence and Associated Psychopathologies: An Opportunity to Intervene in Skin Cancer Clinics* |
| 16:14 – 16:26 | PS04 | Peripheral opioid pathway antagonists: a novel therapy for idiopathic chronic pruritus and nodular prurigo |
| 16:26 – 16:38 | PS05 | Depression and Anxiety in Patients with Bullous Pemphigoid: A Systematic Review. |
| 16:38 – 16:50 | PS06 | Exploring Drivers of Clinical Improvement in Dermatologic-Psychiatric Care |
| 16:50 – 17:02 | PS07 | Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: Results from the Urticaria Voices study *? |
| POSTERS | ||
| PS09 | Pharmacists perceptions of the use of antipsychotics in psychodermatology | |
| PS10 | Assessing the impact of vulval skin conditions on adult patients’ psychosocial and psychosexual wellbeing | |
| PS11 | Quality of life and psychological morbidity in patients with Xanthelasma palpebrum and its association with clinicodemographic parameters. | |
| PS12 | Successful treatment of chronic pruritus and secondary ulceration with aprepitant | |
“Global Health & Equity” aims to advance efforts to improve the skin health and well-being of people and the planet. Focusing on issues that transcend national borders, it is an area of study, research and practice that places a priority on improving health and health equity for all people worldwide. It requires and promotes interdisciplinary collaboration, including extension beyond health sciences, in order to address health issues which combine population-based health prevention with individual level medical intervention. Implied is a specific focus on resource poor settings within the world.
| 14:00 – 14:05 | Introduction
Dr Sidra Khan and Dr David Chandler |
|
| 14:05 – 14:25 | GDGL1 | Invite Talk Title TBC Dr Michele Murdoch (Watford) |
| 14:25 – 14:45 | GDGL2 | Invited Talk Scabies and other ectoparasites, where, at what level, and how to fight them Dr Cristina Galván (Spain) |
| 14:45 – 14:55 | GD04 (P064) |
A study of multidrug resistance pattern in scabies-associated infections in endemic communities Shini Choubey |
| 14:55 – 15:05 | GD02 | Addressing dermatology access barriers: the impact of community economic distress on clinic services Charlotte McRae, Ella Nichols, Connor Sisk, Mike Anderson, Laci Tuner, Rohit Reddy and Tiffany Mayo |
| 15:05 – 15:15 | GD03 | Geopolitics and the skin: the importance of historical awareness in improving early recognition and management of cutaneous conditions in the newly arrived migrant Wendy Rennie, Amy Barrett, Helena Wells and Bruce Gee |
| 15:15 – 15:25 | GD01 | War, conflict and displacement: a clinical vignette of current dermatological issues in affected nations Sami Raza, Bisam-Ul Haq and Yasmin Nikookam |
| 15:25 – 15:30 | Final Comments |
| POSTERS | ||
| GD05 | Evaluating access to diverse dermatology providers across socioeconomically distressed communities in the southern USA Charlotte McRae, Connor Sisk, Ella Nichols, Laci Turner, Mike Anderson, Rohit Reddy and Tiffany Mayo |
|
| GD06 | Terbinafine-resistant Trichophyton indotineae: an analysis of confirmed cases in our regional National Health Service board Louise McKenna, Laura Cottom and Amrita Randhawa |
|
| GD07 | From disability to ability: a clinicoepidemiological study of reconstructive surgeries in a leprosy-endemic district Binodini Behera, Shini Choubey, Prasanjeet Dash and Madan Mohan |
|
| GD08 | Integrating dermatology into Nepal’s cancer control strategy: the role of noninvasive tools like dermoscopy in skin cancer screening and early detection Shambhu Joshi and Dinesh Joshi |
|
| GD09 | Spotted fever after safari: a case of African tick bite fever highlighting the value of eschar swabs for the molecular detection of rickettsial disease Aoife Boyle, Catherine Uhomoibhi, Siân Tiley, Aoife Cotter and Fergal Moloney |
|
| GD10 | Diversity to the forefront: representation of skin types across British Association of Dermatologists medical journal covers Brian Nolan |
|
| GD11 | Scabies in the Mid-West of Ireland: trends and practices in primary care Eimear Duff, Jason Hynes, Fei Lai, Tanveer Hamid and Maeve Lynch |
|
| 14:00 – 14:30 | HGL1 | Invited Talk
A History of Dermatology in Glasgow and the West of Scotland Prior to 1980 Prof Rona Mackie (Glasgow) |
| 14:30 – 14:45 | H01 | Avicenna: An Influence on Modern Dermatology |
| 14:45 – 15:00 | H02 | From Pharaohs to Fluorouracil: the enduring mystery of keloids |
| 15:00 – 15:15 | H03 | Behind Bars: Picasso, Prostitutes, and the Syphilis that Bound Him |
| 15:15 – 15:30 | H04 | From Arsenic to Rituximab: A History of Dermatitis Herpetiformis. |
THURSDAY 3 JULY 2025
| PROGRAMME | ||
| Bench to bedside science BAD and BSID | ||
| 08:30 – 08:45 | O10 | Acne polygenic risk score derived from genome-wide association metaregression enables prediction of severity
Xinyi Du-Harpur, Jessye Maxwell, Brittany L. Mitchell, Luba M. Pardo, Willemijn C.A.M. Witkam, Nick Dand, Meike Bartels, Michael Betti, Dorret I. Boomsma, Xianjun Dong, Zachary Gerring, Sarah Finer, Fiona A. Hagenbeek, Jouke Jan Hottenga, George Hripcsak, Laura Huilaja, Kristian Hveem, Benjamin Jacobs, Mart Kals, James Kaufman-Cook, Johannes Kettunen, Atlas Khan, Kulli Kingo, Krzysztof Kiryluk, Mari Løset, Gerton Lunter, Michelle Lupton, Josine L. Min, Nicholas G. Martin, Sarah E. Medland, Dorien Neijzen, Tamar E.C. Nijsten, Tiit Nikopensius, Catherine M. Olsen, Lynn Petukhova, Anu Reigo, Miguel E. Rentería, Rossella Rispoli, Jake Saklatvala, Eeva Sliz, Kaisa Tasanen-Määttä,, Laurent Thomas, Richard C. Trembath, Mariliis Vaht, David A. van Heel, Chunhua Weng, David C. Whiteman, Jonathan N. Barker, Catherine Smith and Michael A. Simpson |
| 08:45 – 09:00 | LB02 | Late breaking |
| 09:00 – 09:20 | INV11 | Invited Talk Newborn genome screening and genetic skin conditions in the Generation StudyDr David Bick (London) |
| 09:20 – 09:35 | BSID Best Paper | |
| 09:35 – 09:50 | BSID Best Paper | |
| 09:50 – 10:45 | Break | |
| Using science to inform clinical practice: BAD and UKDCTN | ||
| 10:45 – 11:00 | O11 | A patchy prognosis: identification of prognostic factors associated with progression in early-stage mycosis fungoides and first-line treatment selection
Abraham Bashir, Pietro Quaglino, Felicity Evision, Youn Kim and Julia Scarisbrick; on behalf of the PROCLIPI Collaborators |
| 11:00 – 11:15 | O12 | Does frequency of bathing impact eczema symptoms? Results of the first Rapid Eczema Trials project randomized controlled trial
Kim Thomas, Amanda Roberts and the Eczema Bathing Study Team |
| 11:20 – 11:40 | INV12 | Invited Talk
A Journey Of Discovery – Using science to inform clinical practice in skin surgery |
| 11:40 – 11:55 | O13 | Impact of amlitelimab (an anti-OX40 ligand antibody) on atopic dermatitis by body region: post hoc results from the STREAM-AD phase IIb study of moderate-to-severe atopic dermatitis
Andrew E. Pink, Adam Reich, Stephan Weidinger, Vivian Y. Shi, Norito Katoh, Cori Gray, Nicole Armstrong, Mark Bennett, Lindsay Stautzenberger, Charlotte Bernigaud and Kassim Rahawi |
| 11:55 – 12:25 | KL06 | Keynote Lecture
Using Science to inform clinical practice Prof Catherine Smith (London) |
| 13:30 – 13:45 | Inv13 | Invited Talk
Top 3 papers of the year Dr Ewan Langan (Editor-in-Chief, SHD) |
| 13:45 – 14:00 | Inv14 | Invited Talk
Top 3 papers of the year Dr Adam Daunton (Editor-in-Chief, CED) |
| 14:00 – 14:15 | Inv15 | Invited Talk
Top 3 papers of the year Prof John McGrath (Editor-in-Chief, BJD) |
| 14:15 – 14:45 | KL07 | Keynote Lecture
Regenerative medicine Dr James Kirkland (Los Angeles, CA, United States) |
| 14:45 – 15:30 | RO | Arthur Rook Oration
TBC Dr Amy Paller (Chicago, IL, United States) |
| 08:30 – 08:40 | PA01 | Wajeeha Khan. Treating scabies with Oral Ivermectin in infants: Series of 12 cases. |
| 08:40 – 08:50 | PA02 | Nada Khalil. Dupilumab-Induced Eosinophilia in Paediatric Eczema Patients: Pointers for Dermatologists. |
| 08:50 – 09:00 | PA03 | Cathal O’Connor. Trametinib therapy for congenital melanocytic naevi.
|
| 09:00 – 09:10 | PA04 | Jaclyn Tan. Chronic inflammatory skin conditions in adolescents and its impact on intimate relationships.
|
| 09:10 – 09:20 | PA05 | Navin Nagesh. Two self-improving collodion ichthyosis babies with ALOX12B mutations demonstrating novel diagnostic clinical signs. |
| 09:20 – 09:30 | PA06 | Janaani P. Efficacy and safety of oral tofacitinib in children with moderate to severe atopic dermatitis: A Retrospective analysis. |
| 09:30 – 10:00 | PAGL1 | Invited lecture: Dr Alia Ahmed. ADHD and Eczema. |
| 10:00 – 10:45 | Break | Exhibition Hall |
| 10:45 – 11:15 | PAGL2 | Invited lecture: Clare Mackay. Body-focused repetitive behaviours. |
| 11:15 – 11:45 | PAGL3 | Invited lecture: Prof Amy Paller. Title TBC |
| 11:45 – 11:55 | PA07 | Inga Lawson. Sources of Patient Perceptions of Topical Steroid Withdrawal and Developing Framework to Mitigate Bias. |
| 11:55 – 12:05 | PA08 | Luke Carson. The use of dupilumab for complex dermatoses: A case series. |
| 12:05 – 12:15 | PA09 | Katie Creamer, Tracy Bale. Exploring the potential impact of adhering to the MHRA ‘Introduction of new safety measures for Isotretinoin’ guidelines (October 2023). |
| 12:15 – 13:30 | Executive Committee Meeting – In room M3 |
| 08:30 – 08:50 | AGM | |
| 08:50 – 09:00 | PD01 | Liver fibroscanning identifies hepatic fibrosis at an early stage in EPP: a new analysis in 132 patients. |
| 09:00 – 09:10 | PD02 | Xeroderma Pigmentosum: From First Symptoms to Diagnosis |
| 09:10 – 09:20 | PD03 | Normal erythema ranges in diagnostic phototesting |
| 09:20 – 09:30 | PD04 | Shining a Light on Eczema: A Prospective, Comparative, Cohort Study of Dupilumab and JAK Inhibitors in Photosensitive Atopic Dermatitis |
| 09:30 – 09:45 | PD05 | Chronic Actinic Dermatitis – A Multicentre Evaluation |
| 09:45 – 10:15 | PDGL1 | An update on the role of ultraviolet radiation in the pathogenesis of cutaneous lupus erythematosus – Dr Thomas Tull |
| 10:15 – 10:45 | Break | Exhibition Hall |
| 10:45 – 11:15 | PDGL2 | Australia’s Sunbed Ban: Lessons learnt to inform future international policy reform – Prof Craig Sinclair
|
| 11:15 – 11:30 | PD06 | Early insights from a UK registry of patients with vitiligo |
| 11:30 – 11:45 | PD07 | Polymorphic Light Eruption: Insights from a Tertiary Photodiagnostic Service |
| 11:45 – 11:55 | PD08 | Developing an effective intervention to improve photoprotection behaviour in XP: results of the XPAND trial. |
| 11:55 – 12:05 | PD09 | Life Expectancy of Xeroderma Pigmentosum Patients: Evidence from a UK Study |
| 12:05 – 12:20 | The La Roche Posay Fellowship winner |
| POSTERS | ||
| PD10 | Retrospective analysis of phototesting wavelength sensitivity to optimise patient coverage and phototesting efficiency | |
| PD11 | Clinical Features and Prognosis of Actinic Prurigo in Scotland | |
| PD12 | Narrowband UVB and PUVA Phototherapy for Mycosis Fungoides: A 17-Year Retrospective Cohort Study in a University Teaching Hospital (2007-2024)
|
|
| PD13 | Refractory inflammatory dermatoses: 17 years’ British Grenz ray experience
|
|
| PD14 | The first documented case of Rothmund-Thomson Syndrome with UVB photosensitivity confirmed by phototesting
|
|
| PD15 | The Long Road to Diagnosis: A Singe-Centre Study of Delays and Disease Burden in Photodermatoses | |
| PD16 | The Sunscreen Dilemma in Photosensitivity: Navigating UV and Visible Light Protection | |
| PD17 | Skin-derived precursor conditioned medium alleviated photoaging via early activation of TGF-β/Smad signaling pathway by thrombospondin1: In vitro and in vivo studies | |
Details to follow
Details to follow
| 15:45 – 16:15 | PSDGL1 | Invited Talk
TBC |
| 16:15 – 16:30 | PSD01 | Clinical Patterns and Treatment Outcomes of Male Genital Dermatoses: Experience in a UK Specialist Dermatology Service |
| 16:30 – 17:00 | BG02 | Invited Talk
TBC
|
| POSTERS | ||
| PSD02 | Where the Sun don’t Shine: A Rare Case of Genital Lupus Erythematosus | |
| PSD03 | Does the incidence of male genital dermatoses vary with age? | |
| PSD04 | Recurrent and Persistent Genital Ulcers in an Immunocompromised Male: An Uncommon Presentation of Herpes Zoster | |
HOT TOPICS
Details to follow